Biology Reference
In-Depth Information
Stadelmann, B., Scholl, S., Müller, J., Hemphill, A., 2010. Application of an in vitro drug
screening assay based on the release of phosphoglucose isomerase to determine the
structure-activity relationship of thiazolides against
Echinococcus multilocularis
metaces-
todes. J. Antimicrob. Chemother. 65, 512-519.
Sterk, M., Müller, J., Hemphill, A., Müller, N., 2007. Characterization of a
Giardia lamblia
WB C6 clone resistant to the isoflavone formononetin. Microbiology 153, 4150-4158.
Strohbusch, M., Müller, N., Hemphill, A., Greif, G., Gottstein, B., 2008. NcGRA2 as a
molecular target to assess the parasiticidal activity of toltrazuril against
Neospora caninum
.
Parasitology 135, 1065-1073.
Strohbusch, M., Müller, N., Hemphill, A., Krebber, R., Greif, G., Gottstein, B., 2009. Toltra-
zuril treatment of congenitally acquired
Neospora caninum
infection in newborn mice.
Parasitol. Res. 104, 1335-1343.
Timmers, L.F., Pauli, I., Barcellos, G.B., Rocha, K.B., Caceres, R.A., de Azevedo, W.F.J.,
Soares, M.B., 2009. Genomic databases and the search of protein targets for protozoan
parasites. Curr. Drug Targets 10, 240-245.
Torres-Gómez, H., Hernández-Núñez, E., León-Rivera, I., Guerrero-Alvarez, J.,
Cedillo-Rivera, R., Moo-Puc, R., Argotte-Ramos, R., Rodríguez-Gutiérrez, M.C.,
Chan-Bacab, M.J., Navarrete-Vázquez, G., 2008. Design, synthesis and in vitro anti-
protozoal activity of benzimidazole-pentamidine hybrids. Bioorg. Med. Chem. Lett.
18, 3147-3151.
Unoki, M., Brunet, J., Mousli, M., 2009. Drug discovery targeting epigenetic codes: the great
potential of UHRF1, which links DNA methylation and histone modifications, as a
drug target in cancers and toxoplasmosis. Biochem. Pharmacol. 78, 1279-1288.
Upcroft, J.A., Campbell, R.W., Upcroft, P., 1996. Quinacrine-resistant
Giardia duodenalis
.
Parasitology 112, 309-313.
Upcroft, J.A., Upcroft, P., 1993. Drug resistance and
Giardia
. Parasitol. Today 9, 187-190.
Upcroft, P., Upcroft, J.A., 2001. Drug targets and mechanisms of resistance in the anaerobic
protozoa. Clin. Microbiol. Rev. 14, 150-164.
Waller, R.F., Keeling, P.J., Donald, R.G., Striepen, B., Handman, E., Lang-Unnasch, N.,
Cowman, A.F., Besra, G.S., Roos, D.S., McFadden, G.I., 1998. Nuclear-encoded proteins
target to the plastid in
Toxoplasma gondii
and
Plasmodium falciparum
. Proc. Natl. Acad. Sci.
U.S.A. 95, 12352-12357.
Wang, B.H., Ternai, B., Polya, G.M., 1994. Specific inhibition of cyclic AMP-dependent pro-
tein kinase by the antimalarial halofantrine and by related phenanthrenes. Biol. Chem.
Hoppe Seyler 375, 527-535.
Wang, C.C., 1997. Validating targets for antiparasite chemotherapy. Parasitology 114 (Suppl),
S31-S44.
Wang, H.,Yan, Z., Geng, J., Kunz, S., Seebeck, T., Ke, H., 2007. Crystal structure of the
Leish-
mania major
phosphodiesterase LmjPDEB1 and insight into the design of the parasite-
selective inhibitors. Mol. Microbiol. 66, 1029-1038.
Wang, J., Huang, L., Li, J., Fan, Q., Long,Y., Li,Y., Zhou, B., 2010. Artemisinin directly targets
malarial mitochondria through its specific mitochondrial activation. PLoS One 5.
Werbovetz, K.A., 2002. Tubulin as an antiprotozoal drug target. Mini Rev. Med. Chem. 2,
519-529.
Whittaker, S.G., Faustman, E.M., 1991. Effects of albendazole and albendazole sulfoxide on
cultures of differentiating rodent embryonic cells. Toxicol. Appl. Pharmacol. 109, 73-84.
Wilkinson, S.R., Taylor, M.C., Horn, D., Kelly, J.M., Cheeseman, I., 2008. A mechanism for
cross-resistance to nifurtimox and benznidazole in trypanosomes. Proc. Natl. Acad. Sci.
U.S.A. 105, 5022-5027.
Winter, R.W., Kelly, J.X., Smilkstein, M.J., Dodean, R., Hinrichs, D., Riscoe, M.K., 2008.
Antimalarial quinolones
:
synthesis, potency, and mechanistic studies. Exp. Parasitol. 118,
487-497.
Search WWH ::
Custom Search